Search For "active pharmaceutical ingredient"
Sigachi Industries aims to increase Revenue Potential by INR 250 cr Commen
Updated : 4 months, 1 week ago IST
Hyderabad (Telangana) [India], January 23: Sigachi Industries Ltd. (NSE: SIGACHI; BSE: 543389), a leading Indian pharmaceutical company, today announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharm
Read More
Anlon Healthcare Delivers Over 102% Profit Growth in H1 FY26 & 259% in Q2F
Updated : 6 months, 3 weeks ago IST
Rajkot (Gujarat) [India], November 13: Anlon Healthcare Limited, one of India's leading manufacturers of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), announced its unaudited financial results for the second Q2 and H1 FY26.
Read More
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, I
Updated : 8 months ago IST
Hyderabad (Telangana) [India], September 19: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredie
Read More
Sigachi Industries Sets the Gold Standard in Microcrystalline Cellulose (M
Updated : 11 months, 3 weeks ago IST
Hyderabad (Telangana) [India], June 13: Sigachi Industries Ltd., India's largest producer of Microcrystalline Cellulose (MCC), continues to set new benchmarks in global pharmaceutical excipients while strategically expanding into Active Pharmaceutical Ingredients (APIs) and specialty chem
Read More
Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs
Updated : 1 year ago IST
New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform company. This collaboration is focused o
Read More
Florricks Lifecare Expands Global Footprint with USD 95 Million Investment
Updated : 1 year, 3 months ago IST
Mumbai (Maharashtra) [India], February 26: Florricks Lifecare Private Limited, a leading research-driven global pharmaceutical company renowned for its innovative R&D, production, and sales of Active Pharmaceutical Ingredients (API) and Finished Dosage Forms across multiple therapeutic a
Read More
Dansy Labs Announces USD 120 Million Major Strategic Asset Buyout and Pate
Updated : 1 year, 3 months ago IST
New Delhi [India], February 24: In a landmark move aimed at significantly enhancing its research and development capabilities, Dansy Labs Private Limited has announced the strategic acquisition of key assets & Patents in Hong Kong and Sweden. This buyout is expected to bring about substa
Read More
Celebrating the Legacy of Excellence and Innovation, Zydus Takeda Healthca
Updated : 1 year, 4 months ago IST
Mumbai, Vashi (Maharashtra) [India], January 31: Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences Limited and Takeda Pharmaceutical Company Limited (Takeda) (TSE:4502/NYSE:TAK), celebrates the 25th anniversary of the Vashi manufacturing pl
Read More
Macsen Labs Group Commences Construction of New API Manufacturing Facility
Updated : 1 year, 4 months ago IST
Udaipur (Rajasthan) [India], January 6: Macsen Labs Group announces the commencement of construction of its new Active Pharmaceutical Ingredient (API) manufacturing facility near one of its existing units, Macsen Drugs in RIICO Industrial Area, Gudli, Udaipur, Rajasthan, India. This strat
Read More
NPPA approves 50 pc price hike for 11 essential drugs to ensure continued
Updated : 1 year, 7 months ago IST
The move aims to address the financial viability of manufacturing these drugs without compromising the mandate to provide affordable medication. NPPA's primary objective is to ensure that essential medicines are available at reasonable prices.
Read More
Atul Bioscience Ltd Received EIR from the US FDA for its Ambernath Facilit
Updated : 1 year, 9 months ago IST
Mumbai (Maharashtra) [India], August 12: Atul Bioscience Ltd (ABL), a 100 per cent subsidiary company of Atul Ltd, received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility situated in Ambernath, Maharashtra.
Read More
Rusan Pharma's API Plant in Ankleshwar Receives (India) USFDA GMP Approval
Updated : 1 year, 10 months ago IST
Ankleshwar (Gujarat) [India], July 22: RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that the United States Food and Drug Administration (USFDA) has granted Good Manufacturing Prac
Read More